A detailed history of Sectoral Asset Management Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Sectoral Asset Management Inc holds 15,085 shares of BBIO stock, worth $430,375. This represents 0.32% of its overall portfolio holdings.

Number of Shares
15,085
Previous 15,535 2.9%
Holding current value
$430,375
Previous $393,000 2.29%
% of portfolio
0.32%
Previous 0.2%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$23.91 - $31.3 $10,759 - $14,085
-450 Reduced 2.9%
15,085 $384,000
Q2 2024

Aug 13, 2024

SELL
$23.0 - $31.04 $13,110 - $17,692
-570 Reduced 3.54%
15,535 $393,000
Q1 2024

May 14, 2024

BUY
$27.35 - $40.45 $86,152 - $127,417
3,150 Added 24.31%
16,105 $497,000
Q4 2023

Feb 14, 2024

SELL
$24.02 - $43.89 $4.02 Million - $7.34 Million
-167,240 Reduced 92.81%
12,955 $522,000
Q3 2023

Nov 14, 2023

BUY
$16.89 - $35.01 $3.04 Million - $6.31 Million
180,195 New
180,195 $4.75 Million
Q1 2022

May 10, 2022

SELL
$7.34 - $17.16 $2.08 Million - $4.86 Million
-282,950 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$11.38 - $53.41 $2.16 Million - $10.1 Million
-190,000 Reduced 40.17%
282,950 $4.72 Million
Q3 2021

Nov 15, 2021

BUY
$46.87 - $64.24 $6.89 Million - $9.45 Million
147,100 Added 45.14%
472,950 $22.2 Million
Q2 2021

Aug 16, 2021

BUY
$46.47 - $63.93 $6.63 Million - $9.13 Million
142,750 Added 77.96%
325,850 $19.9 Million
Q1 2021

May 14, 2021

BUY
$55.47 - $72.35 $9.82 Million - $12.8 Million
177,100 Added 2951.67%
183,100 $11.3 Million
Q4 2020

Feb 12, 2021

BUY
$38.38 - $71.11 $230,280 - $426,660
6,000 New
6,000 $427,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.23B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.